Business


life sciences and health in the digital age


2030


One of the key ways in which The Pistoia Alliance works with its members is to help them not just deal with the problems of today, but also to look ahead, to anticipate how the industry is going to change, and understand how they might prepare for these changes. As part of this effort, The Pistoia Alliance has developed a research paper which sets out to consider what the life science, biopharma R&D and healthcare ecosystem might look like in 2030. This paper was developed with the input of global healthcare, biopharma and digital experts, during a series of face-to-face meetings in the US and UK.


I


n particular, the 2030 paper looks at how the increasing adoption and sophistication of tech- nology will affect companies and patients


alike. Technology is responsible for the develop- ment of healthcare devices that are transforming the quality and quantity of life. These devices, in combination with medical science, are enabling society to progress from a ‘one-size fits all’ man- agement of disease, to a personalised, preventive and predictive approach, even to the cure of previ- ously incurable disease. The research also looked at the costs which


come with such developments, including the need for society to think of new ways of valuing, cal- culating and funding the costs of healthcare delivery. This is critical because, unless develop- ments in healthcare delivery are encouraged, progress in healthcare delivery will stall, falling short of the WHO Constitution (1946) which states that “…the highest attainable standard of


Drug Discovery World Fall 2019


health is a fundamental right of every human being”. This article is the first in a two-part series based


on The Pistoia Alliance report. Written in retro- spect from the world as it is in 2030, it looks at how healthcare has changed in the intervening decade, covering the socio-economic and political evolutions that have happened, the subsequent effects on population health and the innovative technologies which have had the greatest impact. The intention of this 2030 report is to stimulate


debate as to what the future may hold, and to iden- tify the key areas where stakeholders must work together to advance. There are many scenarios one could legitimately put forward and challenge. We have chosen one such set of scenarios. It is not to say it will be correct. However, in presenting these scenarios it is hoped one can identify signals that identify the likely drivers of change over the next 10 years or so.


43


By Dr Steve Arlington and John Wise


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68